New strategies for targeting the hypoxic tumour microenvironment in breast cancer.

Radiation and drug resistance remain major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Metabolic reprogramming is a recently recognised hallmark of cancer with the hypoxic acidic extracellular environment as a major driver of invas...

Full description

Bibliographic Details
Main Authors: Ward, C, Langdon, S, Mullen, P, Harris, A, Harrison, D, Supuran, C, Kunkler, I
Format: Journal article
Language:English
Published: 2013
_version_ 1826257922563244032
author Ward, C
Langdon, S
Mullen, P
Harris, A
Harrison, D
Supuran, C
Kunkler, I
author_facet Ward, C
Langdon, S
Mullen, P
Harris, A
Harrison, D
Supuran, C
Kunkler, I
author_sort Ward, C
collection OXFORD
description Radiation and drug resistance remain major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Metabolic reprogramming is a recently recognised hallmark of cancer with the hypoxic acidic extracellular environment as a major driver of invasion and metastases. Nearly 40% of all breast cancers and 50% of locally advanced breast cancers are hypoxic and their altered metabolism is strongly linked to resistance to radiotherapy and systemic therapy. The dependence of metabolically adapted breast cancer cells on alterations in cell function presents a wide range of new therapeutic targets such as carbonic anhydrase IX (CAIX). This review highlights preclinical approaches to evaluating an array of targets against tumour metabolism in breast cancer and early phase clinical studies on efficacy.
first_indexed 2024-03-06T18:25:51Z
format Journal article
id oxford-uuid:07f04c3b-a802-4d81-8a91-7d23514384b9
institution University of Oxford
language English
last_indexed 2024-03-06T18:25:51Z
publishDate 2013
record_format dspace
spelling oxford-uuid:07f04c3b-a802-4d81-8a91-7d23514384b92022-03-26T09:10:09ZNew strategies for targeting the hypoxic tumour microenvironment in breast cancer.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:07f04c3b-a802-4d81-8a91-7d23514384b9EnglishSymplectic Elements at Oxford2013Ward, CLangdon, SMullen, PHarris, AHarrison, DSupuran, CKunkler, IRadiation and drug resistance remain major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Metabolic reprogramming is a recently recognised hallmark of cancer with the hypoxic acidic extracellular environment as a major driver of invasion and metastases. Nearly 40% of all breast cancers and 50% of locally advanced breast cancers are hypoxic and their altered metabolism is strongly linked to resistance to radiotherapy and systemic therapy. The dependence of metabolically adapted breast cancer cells on alterations in cell function presents a wide range of new therapeutic targets such as carbonic anhydrase IX (CAIX). This review highlights preclinical approaches to evaluating an array of targets against tumour metabolism in breast cancer and early phase clinical studies on efficacy.
spellingShingle Ward, C
Langdon, S
Mullen, P
Harris, A
Harrison, D
Supuran, C
Kunkler, I
New strategies for targeting the hypoxic tumour microenvironment in breast cancer.
title New strategies for targeting the hypoxic tumour microenvironment in breast cancer.
title_full New strategies for targeting the hypoxic tumour microenvironment in breast cancer.
title_fullStr New strategies for targeting the hypoxic tumour microenvironment in breast cancer.
title_full_unstemmed New strategies for targeting the hypoxic tumour microenvironment in breast cancer.
title_short New strategies for targeting the hypoxic tumour microenvironment in breast cancer.
title_sort new strategies for targeting the hypoxic tumour microenvironment in breast cancer
work_keys_str_mv AT wardc newstrategiesfortargetingthehypoxictumourmicroenvironmentinbreastcancer
AT langdons newstrategiesfortargetingthehypoxictumourmicroenvironmentinbreastcancer
AT mullenp newstrategiesfortargetingthehypoxictumourmicroenvironmentinbreastcancer
AT harrisa newstrategiesfortargetingthehypoxictumourmicroenvironmentinbreastcancer
AT harrisond newstrategiesfortargetingthehypoxictumourmicroenvironmentinbreastcancer
AT supuranc newstrategiesfortargetingthehypoxictumourmicroenvironmentinbreastcancer
AT kunkleri newstrategiesfortargetingthehypoxictumourmicroenvironmentinbreastcancer